September 16, 2023 (Vientiane) Laos BIGBEAR Pharmaceuticals announced has recently made a significant stride in the field of immune inflammatory disease treatment with the approval of four breakthrough Janus kinase (JAK) inhibitors. The Lao Health Authority has given the green light to TOFADX, RUSODX, UPADX, and DUVACIDX, marking a new…
Vientiane, Laos - April 28, 2023 - Big Bear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative therapies for cancer, announced today that it has received approval from the Ministry of Health of Laos for six anti-cancer targeted drugs. The approved drugs are: The approval of these…
El 21 de marzo de 2023, LienTeh anunció una nueva estrategia de contenido destinada a proporcionar información y servicios de longevidad útiles, confiables y centrados en el usuario. Anteriormente, la Red LienTeh se creó originalmente para brindar apoyo durante la pandemia de COVID-19 al promover el equilibrio de atención médica…
On March 21, 2023, LienTeh announced a new content strategy aimed at providing useful, reliable and user-centric longevity information and services. Previously,The LienTeh Network was originally created to provide support during the COVID-19 pandemic by promoting cross-regional healthcare balance and improving access to healthcare resources. After that, the LienTeh network…
The Food and Drug Department of the Ministry of Health in Lao PDR is responsible for regulating the registration of pharmaceutical products in the country . They provide a range of forms and guidelines on their website to assist with the registration process . For instance, you can download the…
El texto original en inglés es más preciso 8 targeted drugs for treatment of the Chronic lymphocytic leukemia(CLL) La leucemia linfocítica crónica (LLC) es un tipo de cáncer de la sangre que comienza en la médula ósea y puede progresar lenta o rápidamente según la forma que adopte. Las terapias…
Chronic lymphocytic leukemia (CLL) is a type of blood cancer that begins in the bone marrow,Can progress either slowly or quickly depending on the form it takes.Current therapies do not offer patients a cure for CLL, but there are treatments that help manage the disease. Chemotherapy and drug therapy, including targeted therapy…
El texto original en inglés es más preciso 4 targeted drugs for treatment of the Endometrial Carcinoma El cáncer de endometrio es una enfermedad en la que se forman células malignas (cancerosas) en los tejidos del endometrio. La obesidad y el síndrome metabólico pueden aumentar el riesgo de cáncer de…
Endometrial cancer is a disease in which malignant (cancer) cells form in the tissues of the endometrium. Obesity and having metabolic syndrome may increase the risk of endometrial cancer. Taking tamoxifen for breast cancer or taking estrogen alone (without progesterone) can increase the risk of endometrial cancer. Targeted therapy is used…
El texto original en inglés es más preciso 3 targeted drugs for treatment of the MET positive cancer MET, también conocido como receptor del factor de crecimiento de hepatocitos (HGFR), es una proteína que participa en el crecimiento, la supervivencia y la migración celular. En algunos tipos de cáncer, el…
MET, also known as the hepatocyte growth factor receptor (HGFR), is a protein that is involved in cellular growth, survival, and migration. In some cancers, the MET gene may become altered or amplified, leading to increased MET signaling and contributing to tumor growth and progression. Several targeted therapies have been developed or are under investigation for the treatment of MET-positive…
El texto original en inglés es más preciso 2 targeted drugs for treatment of the KRAS mutations cancer Ha habido varias terapias dirigidas en desarrollo para el tratamiento de cánceres con mutaciones KRAS. Sotorasib[1] Una de las terapias dirigidas más prometedoras para los cánceres mutantes en KRAS es sotorasib (también…